• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Aberrant Crypt Foci

Aberrant Crypt Foci - 4 Studies Found

Terminated : The Effects of Curcuminoids on Aberrant Crypt Foci in the Human Colon
: Aberrant Crypt Foci
: 2005-09-13
:
  • Drug: sulindac Sulindac 150 mg

Completed : Phase II A Trial of Curcumin Among Patients With Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci)
:
  • Healthy, no Evidence of Disease
  • Tobacco Use Disorder

: 2006-08-16
:
  • Other: laboratory biomarker analysis

Completed : Colonoscopic Removal of Aberrant Crypt Foci: a Prospective, Randomized, Blinded Trial
: Colorectal Neoplasms
: 2008-02-15
:
  • Procedure: Surgical removal of ACF

Completed : Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma
:
  • Adenomatous Polyp
  • Recurrent Colon Cancer
  • Recurrent Rectal
    : 2008-09-17
    :
    • Drug: erlotinib hydrochloride

Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.